Journal article
Treatment of breast and prostate cancer by hypofractionated radiotherapy: potential risks and benefits
- Abstract:
-
Breast cancer and prostate cancer are the most common cancers diagnosed in women and men, respectively, in the UK, and radiotherapy is used extensively in the treatment of both. In vitro data suggest that tumours in the breast and prostate have unique properties that make a hypofractionated radiotherapy treatment schedule advantageous in terms of therapeutic index. Many clinical trials of hypofractionated radiotherapy treatment schedules have been completed to establish the extent to which hy...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Clinical oncology (Royal College of Radiologists (Great Britain)) Journal website
- Volume:
- 27
- Issue:
- 7
- Pages:
- 420-426
- Publication date:
- 2015-07-01
- DOI:
- EISSN:
-
1433-2981
- ISSN:
-
0936-6555
- Source identifiers:
-
512981
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:512981
- UUID:
-
uuid:c46f546c-b62f-4369-8ce0-1f89213f6a7c
- Local pid:
- pubs:512981
- Deposit date:
- 2015-11-20
Terms of use
- Copyright holder:
- Royal College of Radiologists
- Copyright date:
- 2015
- Notes:
-
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record